About this trial
The purpose of this study is to understand DMD functional losses or abilities and their association with independence and quality of life from the perspective of individuals with DMD and/or and their caregivers.
This is a qualitative interview study in which individuals with DMD and/or their caregivers will be asked to participate in a semi-structured, approximately 60- minute interview. Interviews will focus on functional abilities and independence. Caregivers and boys with DMD will be interviewed. This study includes no treatment nor intervention; however, some participants are being treated by a drug that is approved in the U.S. and the U.K. and under investigation in other geographies.
Eligibility criteria
Qualifiers
Have been treated with Givinostat for at least 2 years
Be at least 10 years of age with signed consent of a parent or legal guardian
Be currently taking givinostat
Willing and able to participate in a video and/or audio recorded interview
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Red Nucleus Enterprise Solutions, LLC
Lead sponsor
Italfarmaco S.A
Collaborator